UNDERSTANDING THE MECHANISM OF DRUG-RESISTANT AND TUMOR RECURRENCE IN LIVER CANCER

  • Vasanthakumar Sekar Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.
  • Muthu Dhandapani PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.
  • Babu Balakrishnan PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.
  • Kaleeswaran Balasubramanian PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu, India
  • Sivalingam Azhagu Madhavan PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.
  • Sivamani Ganesan PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Abstract

Chemo-resistant and tumor recurrence are the major hurdle to overcome the cancer patients. Especially in hepatocellular carcinoma (HCC) is notoriously refractory to chemotherapy because of its tendency to develop multi-drug resistance (MDR), through various mechanisms. Aim: The current research is focussed on understanding the mechanism involved in chemo-resistant and tumor recurrence in liver cancer. Methods: Human hepatocellular carcinoma cell line (Huh7) was used entire study. Huh7 cells were cultured with known chemotherapeutic drugs such as 5-FU, Paclitaxel and Cisplatin-based on their Cmax concentration, and then these drug-treated cells were examined for chemoresistant and tumor recurrence properties through flow cytometry analysis, spheroid formation assay, and morphological analysis. Results: In morphological analysis confirm these all the chemo drugs were shown more cytotoxic effete than control, even though there were few viable cells noticed in cisplatin treatment. In flow cytometry analysis cisplatin pre-treated cells were well expressed LCSC marker such as CD133 and stem cell transduction factors like Oct-4 & Nanog than control. In addition to this, all the CD133 expressed cells also expressed to EpCAM. In spheroid formation assay, cisplatin pre-treated cells shown well-defined spheroid than control. Conclusion: LCSC plays a major role in chemoresistant and tumor recurrence through PI3K/Akt/mTOR, wnt-β catenin signaling, NF-kB signaling. So, targeting LCSC through EpCAM targeted therapy along with chemotherapy might be the better option for enhanced prognosis.


Keywords: LCSC, Chemoresistant, Tumor recurrence, Hepatocellular carcinoma.

Keywords: Tumor recurrence, Hepatocellular carcinoma, Chemoresistant

Downloads

Download data is not yet available.

Author Biographies

Vasanthakumar Sekar, Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Muthu Dhandapani, PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Babu Balakrishnan, PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Kaleeswaran Balasubramanian, PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu, India

PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu, India

Sivalingam Azhagu Madhavan, PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

Sivamani Ganesan, PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

PG & Research Department of Zoology and Biotechnology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Thanjavur-613 503, Tamil Nadu.

References

1. Kimura Osamu, Kondo Yasuteru, Kogure Takayuki, et al. Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma. BioMed Res Int Volume, 2014.
2. Kane Robert C, Farrell Ann T, Madabushi Rajanikanth, et al. Sorafenib for the treatment of unresectable hepatocellular carcinoma, Onco, 2009, (14), 95 - 100.
3. Lee TK, Castilho A, Ma S, Ng IO. Liver cancer stem cells: implications for a new therapeutic target, Liver Int, 2009, (29) 955 - 965.
4. Gottesman, M. M. & Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem, 1993, (62), 385–427.
5. Park, J. G. et al. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines, J Natl Cancer Inst, 1994, (86), 700–705.
6. Venkatesh, V. A. et al. Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition, Neoplasia, 2012, (14), 519–525.
7. Wang, L., Mosel, A. J., Oakley, G. G. & Peng, A, Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer, Mol Cancer Ther, 2012, (11), 2401–2409.
8. Comerford, K. M. et al, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, 2002, Cancer Res, (62), 3387–3394.
9. Li, Q. Q. et al, Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells, Clin Cancer Res, 2009, (15), 2657–2665.
10. Van Zijl, F. et al, A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression, Mol Cancer Ther, 2011, (10), 850–860.
11. Liang Wen1,* Chao Liang2,* Enjiang Chen1, Wei Chen1, et al, Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent, Scientific Reports, 2016, (6), 23269.
12. Yang, Z. J., Chee, C. E., Huang, S. & Sinicrope, F. A. The role of autophagy in cancer: therapeutic implications, Mol Cancer Ther, 2011, (10), 1533–1541.
13. Martin, V. et al, Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumor stem cells, Br J Cancer, 2013, 108.
14. Baguley, B. C. Tumor stem cell niches: a new functional framework for the action of anticancer drugs, Recent Pat Anticancer Drug Discov, 2006, (1), 121–127.
15. Wu, Q., Yang, Z., Nie, Y., Shi, Y. & Fan, D. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches, Cancer Lett, 2014, (347), 159–166.
16. Teicher, B. A. Acute and chronic in vivo therapeutic resistance, Biochem Pharmacol, 2009, (77), 1665–1673.
17. Esmatabadi MJ1, Bakhshinejad B, Motlagh FM, Babashah S, Sadeghizadeh M, Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of a tumor coming back, J Biosci, 2016, 41(3):497-506.
18. Is tumor growth sustained by rare cancer stem cells or dominant clones, Cancer Res, 2008, (68), 4018–402.
19. Dick JE, Looking ahead in cancer stem cell research, Nat Biotechnology, 2009, 27(1):44–46.
20. Gedaly R, Galuppo R, Daily MF, Shah M, Maynard E, et al, Targeting the Wnt/b-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535, PLoS ONE, 2014, 9(6), e99272.
21. Yi Chen, Dongke Yu, Hao Zhang, Hongwei He et al, CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor-Initiating Cells in Hepatocellular Carcinoma Huh7 Cells, Int. J. Biol. Sci, 2012, 8(7), 992-1004.
22. Taro Yamashita1, Junfang Ji1, Anuradha Budhu1 Marshonna Forgues1 et al, EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features, Gastroenterology, 2009, 136(3), 1012–1024.
Statistics
52 Views | 109 Downloads
How to Cite
Sekar, V., Dhandapani, M., Balakrishnan, B., Balasubramanian, K., Madhavan, S. A., & Ganesan, S. (2018). UNDERSTANDING THE MECHANISM OF DRUG-RESISTANT AND TUMOR RECURRENCE IN LIVER CANCER. Journal of Drug Delivery and Therapeutics, 8(5), 224-229. https://doi.org/10.22270/jddt.v8i5.1863